Search
Sunday 7 June 2015
  • :
  • :
Latest Update

Investor’s Watch List- Nationstar Mortgage Holdings (NYSE:NSM), International Game Technology Ordinary Shares (NYSE:IGT), Oncothyreon (NASDAQ:ONTY), Imperva Inc (NYSE:IMPV)

On Friday, Nationstar Mortgage Holdings Inc (NYSE:NSM)’s shares declined -2.58% to $19.98.

Nationstar Mortgage Holdings Inc (NSM) reported financial results for its first quarter ended March 31, 2015.

Nationstar stated a quarterly net loss of $48 million, or $(0.53) per share, for the first quarter, contrast to net income of $19 million, or $0.21 per share, in the fourth quarter 2014. GAAP EPS reduced sequentially principally due to a $110 million, or $0.77 per share, non-cash decrease in fair value mark-to-market adjustments in the servicing segment and a $17 million non-cash, or $0.12 per share, quarterly enhance in amortization partially offset by an enhance in earnings from the originations business.

Nationstar generated $114 million of adjusted cash flow during the quarter, a $31 million enhance over the preceding quarter. Nationstar believes that adjusted cash flow provides a better view of the underlying performance of the businesses, counting the Company’s ability to make planned investments.

Nationstar Mortgage Holdings Inc. provides servicing, origination, and transaction based services to single-family residences in the United States. It operates in three segments: Servicing, Originations, and Solutionstar.

PROFILE

International Game Technology Ordinary Shares (NYSE:IGT)’s shares dropped -2.22% to $20.72.

International Game Technology Ordinary Shares (IGT) has been ranked as a Champion, the highest possible rating, in Info-Tech Research Group’s iGaming Platforms Vendor Landscape for the Gaming and Hospitality Research Center.

The Info-Tech Research Group’s Vendor Landscape reports recognize outstanding vendors in the technology marketplace. They assess vendors by the strength of their offering and their strategy for the enterprise, paying tribute to the contribution of exceptional vendors in a particular category.

For this iGaming Platforms Vendor Landscape, Info-Tech focused on those vendors that offer broad capabilities across multiple platforms and that have a strong market presence and/or reputational presence among mid- to large-sized enterprises. IGT was one of 11 vendors chosen for the assessment, and received exemplary scores for product features, vendor viability and vendor strategy, and good scores for product usability, product architecture, vendor reach and vendor integration. IGT’s Champion status represents the highest ranking, followed by Market Pillar, Innovator and Emerging Player.

International Game Technology PLC develops software and hardware solutions for gaming, lottery, interactive, and social sectors through retail, Web, and mobile channels in North America and Europe. It provides online lottery transaction processing systems; a suite of lottery-enabled point of sale terminals; supplies instant ticket games; operates press; and provides instant ticket marketing plans, graphic design, programming, production, packaging, and shipping and delivery services.

At the end of Friday’s trade, Oncothyreon Inc (USA) (NASDAQ:ONTY)‘s shares surged 19.86% to $1.75.

Oncothyreon Inc (USA) (ONTY) declared that it will conduct a conference call on Monday, May 11, 2015 at 4:30 p.m. Eastern Time to talk about its first quarter 2015 financial results.

Oncothyreon Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. Its clinical-stage product candidates comprise ONT-380, an orally active and selective small-molecule HER2 inhibitor, which is in two Phase 1b trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin; and ONT-10, a therapeutic vaccine in Phase 1 trial targeting the Mucin 1 peptide antigen (MUC1) for use in various cancer indications, counting breast, thyroid, colon, stomach, pancreas, ovarian, and prostate, in addition to certain types of lung cancer.

Imperva Inc (NYSE:IMPV), ended its Friday’s trading session with 19.66% gain, and closed at $53.98.

Imperva Inc (IMPV) declared financial results for the first quarter ended March 31, 2015.

First Quarter 2015 Financial Highlights

  • Revenue:Total revenue for the first quarter of 2015 was $44.8 million, an enhance of 42% contrast to $31.5 million in the first quarter of 2014. Within total revenue, product revenue was $17.1 million, up 43% contrast to $12.0 million in the same period last year. Services revenue raised 41% year-over-year to $27.7 million and accounted for 62% of total revenue. Within services revenue, overall subscription revenue grew 89% to $8.7 million, contrast to the first quarter of 2014. Combined product and subscriptions revenue was $25.8 million, an enhance of 56% contrast to $16.6 million in the first quarter of 2014.

First Quarter and Recent Operating Highlights

  • During the first quarter of 2015, Imperva booked 91 deals with a value over $100,000, an enhance of 36% contrast to 67 deals during the first quarter of last year.
  • During the first quarter of 2015, Imperva added 150 new customers contrast to 171 during the first quarter of last year. Imperva now has over 3,900 customers in more than 90 countries around the world.
  • Imperva declared a new version of its Skyfence Cloud Gateway that provides IT staff superior visibility over contextual risk factors specific to their cloud application users and implementations.

Imperva, Inc. develops, markets, sells, services, and supports cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. It operates in two segments, Imperva and Incapsula.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *